Cas No.: | 894787-30-5 |
Chemical Name: | Spiro[pyrrolidine-2,7'(6'H)-[2H]pyrrolo[2,1-b][1,3]thiazine]-4'-carboxamide, 1-[2-[4-[[2-(2,4-dichlorophenoxy)acetyl]amino]phenyl]acetyl]tetrahydro-6'-oxo-, (2R,4'R,8'aR)- |
Synonyms: | ST 2825;ST2825 |
SMILES: | ClC1C=CC(OCC(NC2C=CC(CC(N3CCC[C@@]43C[C@H]3SCC[C@H](C(=O)N)N3C4=O)=O)=CC=2)=O)=C(Cl)C=1 |
Formula: | C27H28Cl2N4O5S |
M.Wt: | 591.506 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A synthetic peptido-mimetic compound that inhibits MyD88 dimerization in a TIR-dependent manner; interferes with recruitment of IRAK1 and IRAK4 by MyD88, causing inhibition of IL-1beta-mediated activation of NF-kappaB transcriptional activity; inhibits IL-1beta-induced production of IL-6 in treated mice, suppresses B cell proliferation and differentiation into plasma cells in response to CpG-induced activation of TLR9; orally active. |